Company: OSRH
Filing Date: 2025-01-31
Form Type: 424B3
Source: 0001213900-25-008874
Chunk: 15

Company: OSR Holdings, Inc.
Filing Date: 2025-01-31
Form: 424B3
Chunk 15
---
ITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE TRANSACTIONS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT/PROSPECTUS, PASSED UPON THE MERITS OR FAIRNESS OF EITHER THE BUSINESS COMBINATION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED THEREBY, OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE ACCOMPANYING PROXY STATEMENT/PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY CONSTITUTES A CRIMINAL OFFENSE. The accompanying proxy statement/prospectus is dated January 31, 2025 and is first being mailed to stockholders on or about January 31, 2025.

BELLEVUE LIFE SCIENCES ACQUISITION CORP. 10900 NE 4 TH STREET, SUITE 2300, BELLEVUE, WA, 98004 NOTICE OF SPECIAL MEETING TO BE HELD ON FEBRUARY 13, 2025 TO THE STOCKHOLDERS OF BELLEVUE LIFE SCIENCES ACQUISITION CORP.: NOTICE IS HEREBY GIVEN that a special meeting of Bellevue Life Sciences Acquisition Corp., a Delaware corporation (“ BLAC”), will be held at 10:00 a.m. Eastern Time, on February 13, 2025 at 10900 NE 4 thStreet, Suite 2300, Bellevue, WA 98004, or at such other time, on such other date to which the meeting may be adjourned or postponed (the “special meeting”). You are cordially invited to attend the special meeting, which will be held for the following purposes: • Proposal No. 1 — The Business Combination Proposal —to consider and vote upon a proposal (i) to approve the business combination (the “Business Combination”) reflected by (a) the Amended and Restated Business Combination Agreement dated as of May23, 2024, as amended on December20, 2024 (as may be amended, supplemented or otherwise modified from time to time, the “ Business Combination Agreement”), copies of which are attached to and incorporated into the proxy statement/prospectus enclosed with this Notice as Annex A and Annex B, respectively, by and among BLAC, OSR Holdings, Ltd., a corporation organized under the laws of the Republic of Korea (“ OSR Holdings”), each holder of shares of OSR Holdings’ Series A common stock, with